Financhill
Buy
59

HEAL Quote, Financials, Valuation and Earnings

Last price:
$9.37
Seasonality move :
-2.28%
Day range:
$9.37 - $9.49
52-week range:
$8.16 - $11.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
717
Avg. volume:
9.1K
1-year change:
9.33%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
HEAL
Global X HealthTech ETF
-- -- -- -- --
AGNG
Global X Aging Population ETF
-- -- -- -- --
CTEC
Global X CleanTech ETF
-- -- -- -- --
EVX
VanEck Environmental Services ETF
-- -- -- -- --
GNOM
Global X Genomics & Biotechnology ETF
-- -- -- -- --
SLX
VanEck Steel ETF
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
HEAL
Global X HealthTech ETF
$9.49 -- -- -- $0.00 0% --
AGNG
Global X Aging Population ETF
$30.68 -- -- -- $0.15 0.82% --
CTEC
Global X CleanTech ETF
$5.96 -- -- -- $0.08 1.77% --
EVX
VanEck Environmental Services ETF
$34.91 -- -- -- $0.16 0.46% --
GNOM
Global X Genomics & Biotechnology ETF
$8.10 -- -- -- $0.00 0% --
SLX
VanEck Steel ETF
$60.16 -- -- -- $2.08 3.46% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
HEAL
Global X HealthTech ETF
-- 2.031 -- --
AGNG
Global X Aging Population ETF
-- 0.900 -- --
CTEC
Global X CleanTech ETF
-- 1.365 -- --
EVX
VanEck Environmental Services ETF
-- 1.021 -- --
GNOM
Global X Genomics & Biotechnology ETF
-- 2.240 -- --
SLX
VanEck Steel ETF
-- 1.171 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
HEAL
Global X HealthTech ETF
-- -- -- -- -- --
AGNG
Global X Aging Population ETF
-- -- -- -- -- --
CTEC
Global X CleanTech ETF
-- -- -- -- -- --
EVX
VanEck Environmental Services ETF
-- -- -- -- -- --
GNOM
Global X Genomics & Biotechnology ETF
-- -- -- -- -- --
SLX
VanEck Steel ETF
-- -- -- -- -- --

Global X HealthTech ETF vs. Competitors

  • Which has Higher Returns HEAL or AGNG?

    Global X Aging Population ETF has a net margin of -- compared to Global X HealthTech ETF's net margin of --. Global X HealthTech ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    HEAL
    Global X HealthTech ETF
    -- -- --
    AGNG
    Global X Aging Population ETF
    -- -- --
  • What do Analysts Say About HEAL or AGNG?

    Global X HealthTech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X HealthTech ETF has higher upside potential than Global X Aging Population ETF, analysts believe Global X HealthTech ETF is more attractive than Global X Aging Population ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    HEAL
    Global X HealthTech ETF
    0 0 0
    AGNG
    Global X Aging Population ETF
    0 0 0
  • Is HEAL or AGNG More Risky?

    Global X HealthTech ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.798, suggesting its less volatile than the S&P 500 by 20.223%.

  • Which is a Better Dividend Stock HEAL or AGNG?

    Global X HealthTech ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Global X Aging Population ETF offers a yield of 0.82% to investors and pays a quarterly dividend of $0.15 per share. Global X HealthTech ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HEAL or AGNG?

    Global X HealthTech ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Global X HealthTech ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Global X HealthTech ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X HealthTech ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HEAL
    Global X HealthTech ETF
    -- -- -- --
    AGNG
    Global X Aging Population ETF
    -- -- -- --
  • Which has Higher Returns HEAL or CTEC?

    Global X CleanTech ETF has a net margin of -- compared to Global X HealthTech ETF's net margin of --. Global X HealthTech ETF's return on equity of -- beat Global X CleanTech ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    HEAL
    Global X HealthTech ETF
    -- -- --
    CTEC
    Global X CleanTech ETF
    -- -- --
  • What do Analysts Say About HEAL or CTEC?

    Global X HealthTech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X CleanTech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X HealthTech ETF has higher upside potential than Global X CleanTech ETF, analysts believe Global X HealthTech ETF is more attractive than Global X CleanTech ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    HEAL
    Global X HealthTech ETF
    0 0 0
    CTEC
    Global X CleanTech ETF
    0 0 0
  • Is HEAL or CTEC More Risky?

    Global X HealthTech ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X CleanTech ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock HEAL or CTEC?

    Global X HealthTech ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Global X CleanTech ETF offers a yield of 1.77% to investors and pays a quarterly dividend of $0.08 per share. Global X HealthTech ETF pays -- of its earnings as a dividend. Global X CleanTech ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HEAL or CTEC?

    Global X HealthTech ETF quarterly revenues are --, which are smaller than Global X CleanTech ETF quarterly revenues of --. Global X HealthTech ETF's net income of -- is lower than Global X CleanTech ETF's net income of --. Notably, Global X HealthTech ETF's price-to-earnings ratio is -- while Global X CleanTech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X HealthTech ETF is -- versus -- for Global X CleanTech ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HEAL
    Global X HealthTech ETF
    -- -- -- --
    CTEC
    Global X CleanTech ETF
    -- -- -- --
  • Which has Higher Returns HEAL or EVX?

    VanEck Environmental Services ETF has a net margin of -- compared to Global X HealthTech ETF's net margin of --. Global X HealthTech ETF's return on equity of -- beat VanEck Environmental Services ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    HEAL
    Global X HealthTech ETF
    -- -- --
    EVX
    VanEck Environmental Services ETF
    -- -- --
  • What do Analysts Say About HEAL or EVX?

    Global X HealthTech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Environmental Services ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X HealthTech ETF has higher upside potential than VanEck Environmental Services ETF, analysts believe Global X HealthTech ETF is more attractive than VanEck Environmental Services ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    HEAL
    Global X HealthTech ETF
    0 0 0
    EVX
    VanEck Environmental Services ETF
    0 0 0
  • Is HEAL or EVX More Risky?

    Global X HealthTech ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison VanEck Environmental Services ETF has a beta of 1.059, suggesting its more volatile than the S&P 500 by 5.86%.

  • Which is a Better Dividend Stock HEAL or EVX?

    Global X HealthTech ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VanEck Environmental Services ETF offers a yield of 0.46% to investors and pays a quarterly dividend of $0.16 per share. Global X HealthTech ETF pays -- of its earnings as a dividend. VanEck Environmental Services ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HEAL or EVX?

    Global X HealthTech ETF quarterly revenues are --, which are smaller than VanEck Environmental Services ETF quarterly revenues of --. Global X HealthTech ETF's net income of -- is lower than VanEck Environmental Services ETF's net income of --. Notably, Global X HealthTech ETF's price-to-earnings ratio is -- while VanEck Environmental Services ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X HealthTech ETF is -- versus -- for VanEck Environmental Services ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HEAL
    Global X HealthTech ETF
    -- -- -- --
    EVX
    VanEck Environmental Services ETF
    -- -- -- --
  • Which has Higher Returns HEAL or GNOM?

    Global X Genomics & Biotechnology ETF has a net margin of -- compared to Global X HealthTech ETF's net margin of --. Global X HealthTech ETF's return on equity of -- beat Global X Genomics & Biotechnology ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    HEAL
    Global X HealthTech ETF
    -- -- --
    GNOM
    Global X Genomics & Biotechnology ETF
    -- -- --
  • What do Analysts Say About HEAL or GNOM?

    Global X HealthTech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Genomics & Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X HealthTech ETF has higher upside potential than Global X Genomics & Biotechnology ETF, analysts believe Global X HealthTech ETF is more attractive than Global X Genomics & Biotechnology ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    HEAL
    Global X HealthTech ETF
    0 0 0
    GNOM
    Global X Genomics & Biotechnology ETF
    0 0 0
  • Is HEAL or GNOM More Risky?

    Global X HealthTech ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Genomics & Biotechnology ETF has a beta of 1.295, suggesting its more volatile than the S&P 500 by 29.533%.

  • Which is a Better Dividend Stock HEAL or GNOM?

    Global X HealthTech ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Global X Genomics & Biotechnology ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Global X HealthTech ETF pays -- of its earnings as a dividend. Global X Genomics & Biotechnology ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HEAL or GNOM?

    Global X HealthTech ETF quarterly revenues are --, which are smaller than Global X Genomics & Biotechnology ETF quarterly revenues of --. Global X HealthTech ETF's net income of -- is lower than Global X Genomics & Biotechnology ETF's net income of --. Notably, Global X HealthTech ETF's price-to-earnings ratio is -- while Global X Genomics & Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X HealthTech ETF is -- versus -- for Global X Genomics & Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HEAL
    Global X HealthTech ETF
    -- -- -- --
    GNOM
    Global X Genomics & Biotechnology ETF
    -- -- -- --
  • Which has Higher Returns HEAL or SLX?

    VanEck Steel ETF has a net margin of -- compared to Global X HealthTech ETF's net margin of --. Global X HealthTech ETF's return on equity of -- beat VanEck Steel ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    HEAL
    Global X HealthTech ETF
    -- -- --
    SLX
    VanEck Steel ETF
    -- -- --
  • What do Analysts Say About HEAL or SLX?

    Global X HealthTech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Steel ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X HealthTech ETF has higher upside potential than VanEck Steel ETF, analysts believe Global X HealthTech ETF is more attractive than VanEck Steel ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    HEAL
    Global X HealthTech ETF
    0 0 0
    SLX
    VanEck Steel ETF
    0 0 0
  • Is HEAL or SLX More Risky?

    Global X HealthTech ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison VanEck Steel ETF has a beta of 1.401, suggesting its more volatile than the S&P 500 by 40.096%.

  • Which is a Better Dividend Stock HEAL or SLX?

    Global X HealthTech ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VanEck Steel ETF offers a yield of 3.46% to investors and pays a quarterly dividend of $2.08 per share. Global X HealthTech ETF pays -- of its earnings as a dividend. VanEck Steel ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HEAL or SLX?

    Global X HealthTech ETF quarterly revenues are --, which are smaller than VanEck Steel ETF quarterly revenues of --. Global X HealthTech ETF's net income of -- is lower than VanEck Steel ETF's net income of --. Notably, Global X HealthTech ETF's price-to-earnings ratio is -- while VanEck Steel ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X HealthTech ETF is -- versus -- for VanEck Steel ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HEAL
    Global X HealthTech ETF
    -- -- -- --
    SLX
    VanEck Steel ETF
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Bill Ackman Buy Brookfield Stock?
Why Did Bill Ackman Buy Brookfield Stock?

Bill Ackman of Pershing Square Capital has made a number…

Why Is Chewy Stock Up — And Will It Keep Climbing?
Why Is Chewy Stock Up — And Will It Keep Climbing?

We are all witnesses to the crazy e-commerce industry boom…

Is Netflix a Must-own Stock?
Is Netflix a Must-own Stock?

The early months of 2025 have been very hard on…

Stock Ideas

Buy
61
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 38x

Alerts

Sell
27
SAIA alert for Apr 26

Saia [SAIA] is down 30.77% over the past day.

Sell
48
APPF alert for Apr 26

AppFolio [APPF] is down 18.16% over the past day.

Sell
15
KNSL alert for Apr 26

Kinsale Capital Group [KNSL] is down 16.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock